FDA Rejects Tenapanor for Control of Phosphorus in Kidney Disease ...Middle East

An additional trial showing a 'clinically relevant treatment effect' needed for approval in patients with kidney disease on dialysis, says the FDA in response to a new drug application. Medscape Medical News

Hence then, the article about fda rejects tenapanor for control of phosphorus in kidney disease was published today ( Thursday 05/08/2021 - 08:01 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Rejects Tenapanor for Control of Phosphorus in Kidney Disease )

Also on site :

• Isomer's Brightening Anti-Aging Duo Is Perfect for Women Over 50, and Shoppers Confirm It's 'So Good'
• How much? NATO chief calls for ‘Ukraine tax’ bigger than members’ economies
• ‘Fatherland’ Review: Pawel Pawlikowski’s Meditation On Postwar Germany Is A Masterclass In Artistic Discipline – Cannes Film Festival